Carolyn McClanahan, director of financial planning at Life Planning Partners, explains how to become an empowered patient and equip yourself to push back against large medical bills. » Read More
By: Tiffany Hsu
Amid concerns that consumers face too many warnings, a California agency is moving to nullify a judge’s ruling that coffee be accompanied with a cancer notice, The New York Times reports. » Read More |
By: Nina Martin
From the Mayo Clinic to Harvard, sources don't always get the facts right about preeclampsia which is one of the most common cases of maternal death and severe complication in the US, ProPublica reports. » Read More |
By: Zlati Meyer
Plant-based proteins are trending in the US and Starbucks is hopping on board, USA Today reports. » Read More |
Patients can't easily get their health data. Microsoft, Amazon and others want to change that.
Experimental gene therapies have yielded promising results in curing hemophilia in early trials. But the drugs have left some patients wary, worried that success will not last, The New York Times reports.
But Dr. Cosgrove says it remains a major health crisis, due especially to drugs laced with synthetic opioids such as fentanyl.
Health care is among the leading sectors on the S&P 500 so far this year.
A nasal spray sold under the CVS health brand is being recalled because it may lead to life-threatening infections for certain patients, USA Today reports.
Famed activist investor Carl Icahn published a searing letter Tuesday opposing Cigna's $54 billion acquisition of pharmacy benefit manager Express Scripts.
While the U.S. Department of Justice may not have plans to challenge the $69 billion mega-merger of CVS and Aetna, patients and physicians should do so at every turn, says Dr. Theresa Rohr-Kirchgraber.
Shares of global biotechnology company Novozymes slumped Friday morning after reporting second-quarter earnings that missed analysts' expectations.
Amazon's plan is to hire a small number of doctors to start a pilot clinic later this year for a select group of employees and then expand it to more workers in early 2019, according to people familiar with the matter.
Plastic surgeons say they've noticed an alarming trend of what they call "Snapchat dysmorphia," where patients want to look like a filter in a Snapchat selfie, The Hill reports. And yes, the doctors are diagnosing it as a mental condition.
A prestigious Japanese medical school has confessed to rigging its entrance exams against women for more than a decade, The Financial Times reports.
Rite Aid Corporation and Albertsons Companies announced on Wednesday they are terminating their merger agreement the evening ahead of a shareholder vote over the deal.
The longhorned tick has now made an appearance in eight different states on the eastern part of the US, USA Today reports.
The American Medical Association urged the U.S. Justice Department on Wednesday to stop CVS Health Corp's plan to buy insurance provider Aetna, saying the deal could result in higher prices for prescription medicines.
This spring's large E.coli outbreak may have been caused by a large industrial farm in Yuma, Arizona, USA Today reports.
CVS says it returns about 98 percent of rebates to its customers. It expects to keep about $300 million this year, representing about 3 percent of its annual adjusted earnings per share.
Get the best of CNBC in your inbox
Data also provided by 
